Skip to main content
. Author manuscript; available in PMC: 2023 May 1.
Published in final edited form as: Acad Pediatr. 2021 Jul 10;22(4):542–550. doi: 10.1016/j.acap.2021.07.003

Table 1.

Comparison of Respondents and Non-respondents and Additional Characteristics of Respondents and their Practices

Characteristic Total Respondents (N=303) Total Non-Respondents (N=145) P-value, chi-squared test, respondents vs. non-respondents
Provider gender, % (n)
Female 64 (195) 66 (96) 0.70
Male 36 (108) 34 (49)
Mean (SD) provider age in years 53.0 (10.4) 51.8 (10.9) 0.24*
Practice setting, % (n)
Private practice 79 (240) 81 (117)
Hospital or clinic 17 (52) 15 (22)
HMO 4 (11) 4 (6) 0.85
Practice location, % (n)
Rural/Suburban 49 (147) 43 (62) 0.25
Urban 52 (156) 57 (83)
 
Practice region, % (n)
South 34 (104) 44 (64)
Midwest 23 (70) 18 (26)
West 19 (58) 23 (34)
Northeast 23 (71) 15 (21) 0.04
Practice-level decision-making about vaccines, % (n)
Larger System Level 29 (86) 31 (44)
Independent 71 (208) 69 (99) 0.74
Median (IQR) number of providers in practice 6.0 (3.5–9.0) 5.0 (3.0–10.5) 0.74
Proportion of privately insured patients in practice, % (n)
0–24 24 (72) N/A
25–49 23 (48) N/A
≥50 53 (159) N/A
Proportion of Medicaid or your state’s Children’s Health Insurance patients in practice, % (n)
0–24 40 (117) N/A
25–49 27 (79) N/A
≥50 33 (97) N/A
Patient race/ethnicity in practice, % (n)
≥10% Black/African American 58 (171) N/A
≥10% Hispanic 55 (164) N/A
≥10% Asian/Pacific Islander 32 (96) N/A

IQR: interquartile range; SD: standard deviation.

*

t-test,

**

Fisher’s Exact test,

Wilcoxon Test